Showing results (1-10 of 313) with videos related to
Sort By:
Pageof 32
Therapeutic Advances in Hematology|August 9, 2013
Genetic predispositions to childhood leukemiaElliot Stieglitz, Mignon L LohBlood Advances|September 15, 2021
Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatmentAstrid Wintering, Christopher C Dvorak, Elliot Stieglitz, et al.Blood Advances|August 31, 2021
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemiaCarolina E Morales, Elliot Stieglitz, Scott C Kogan, et al.Blood Advances|September 23, 2021
JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1βYuhan Yan, Lei Dong, Chao Chen, et al.Pediatric Blood & Cancer|July 27, 2019
Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemiaAnna Hecht, Julia Meyer, Farid F Chehab, et al.British Journal of Haematology|June 1, 2011
Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemiaMignon L LohHematology. American Society of Hematology. Education Program|January 18, 2011
Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemiaMignon L LohCurrent Opinion in Hematology|June 4, 2002
TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approachesMignon L Loh, Jeffrey E RubnitzFrontiers in Pediatrics|April 16, 2014
Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantationChristopher C Dvorak, Mignon L LohPageof 32